ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Steven N. Hochwald
Matched on ORCID iD 0000-0002-4392-2852; OpenAlex author ID A5051071188. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 2, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2011: 1 paper · 2012: none · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers
Papers 9
- Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2017.10.029↗
- Ablative Therapies for Locally Advanced Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000000948↗
- Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma? Last author DOI 10.1016/j.hpb.2017.03.002↗
- Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome. Co-author DOI 10.1016/j.hpb.2016.02.004↗
- Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer. First author DOI 10.1093/jnci/djv424↗
- A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Last author DOI 10.4161/15384101.2014.949550↗
- Plasma adiponectin: a possible link between fat metabolism and pancreatic cancer risk. First author DOI 10.1093/jnci/djs522↗
- Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo. Last author DOI 10.2174/1871520611313040009↗
- Focal adhesion kinase signaling and function in pancreatic cancer. Co-author DOI 10.2741/e283↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianliang Zhang · 4 shared papers, 2013–2016 · strength 0.30
- Paper Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer. DOI 10.1093/jnci/djv424↗
- Paper Plasma adiponectin: a possible link between fat metabolism and pancreatic cancer risk. DOI 10.1093/jnci/djs522↗
- Paper A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cel… DOI 10.4161/15384101.2014.949550↗
- Boris W. Kuvshinoff · 3 shared papers, 2016–2018 · strength 0.27
- Paper Ablative Therapies for Locally Advanced Pancreatic Cancer. DOI 10.1097/mpa.0000000000000948↗
- Paper Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma? DOI 10.1016/j.hpb.2017.03.002↗
- Paper Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome. DOI 10.1016/j.hpb.2016.02.004↗
- Katherine T. Ostapoff · 2 shared papers, 2017–2018 · strength 0.20
- Emmanuel M Gabriel · 2 shared papers, 2016–2017 · strength 0.15
- Rupen A. Shah · 1 shared paper, 2018 · strength 0.12
- Dhyan Chandra · 1 shared paper, 2018 · strength 0.07
- Sandeep Kumar · 1 shared paper, 2018 · strength 0.07
- Xinjiang Wang · 1 shared paper, 2018 · strength 0.07
- Scott W. Baldwin · 1 shared paper, 2016 · strength 0.07
- Elena Kurenova · 1 shared paper, 2013 · strength 0.04
- Deniz A. Uçar · 1 shared paper, 2013 · strength 0.04
- Saı̈d M. Sebti · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.